Skip to Main Content
Insider Trading

Last Updated: 1 year, 1 month ago

Mudit K. Jain has an estimated net worth of at least $12.0 million*, as of Jan. 29, 2025. They own 985,833 shares of CVRX stock. They have sold 0 shares of CVRX stock since 2021, for an estimated $-4.1 million.

Mudit K. Jain $CVRX SEC Form 4 Insider Trading

Mudit K. Jain has filed a total of 9 insider trades in $CVRX since 2021. Their most recent trade was a purchase of 46,800 shares, made on Feb 20, 2026. Their largest trade was a purchase of 222,222 shares, made on Jul 02, 2021. We estimate that they now own 985,833 shares of $CVRX, worth an estimated $16.1 million.



Insider Trading at $CVRX

There have been a total of 54 insider trades reported at $CVRX since 2021, with 1.8 million shares purchased and 92,636 shares sold. The most active insider traders in $CVRX stock have been Paul Verrastro, Kevin Hykes, and Jared Oasheim. The most recent trade was a sale of 1,262 shares reported by Philip B. Adamson (Chief Medical Officer), made on Mar 02, 2026.



History of Insider Stock Trades by Mudit K. Jain

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
CVRX logo CVRX Purchase 46,800 Feb 20, 2026 Feb. 23, 2026, 7 a.m.
CVRX logo CVRX Purchase 600 Feb 18, 2026 Feb. 18, 2026, 6:22 p.m.
CVRX logo CVRX Purchase 1,500 May 12, 2025 May 13, 2025, 7:12 p.m.
CVRX logo CVRX Purchase 150 May 13, 2025 May 13, 2025, 7:12 p.m.
CVRX logo CVRX Purchase 300 Nov 19, 2021 Nov. 19, 2021, 6:54 p.m.
CVRX logo CVRX Purchase 875 Nov 18, 2021 Nov. 19, 2021, 6:54 p.m.
CVRX logo CVRX Purchase 625 Aug 12, 2021 Aug. 15, 2021, 8 p.m.
CVRX logo CVRX Purchase 222,222 Jul 02, 2021 July 1, 2021, 8 p.m.
CVRX logo CVRX Purchase 1,000 Jul 01, 2021 July 1, 2021, 8 p.m.




$CVRX Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.